
Respiratory and general medicine consultant NHS Scotland | Happiest on Horseback | @sclf_ alumni | #zerowaste | #bekind | All views my own
Scotland, United Kingdom
Joined December 2010
- Tweets1.9K
- Following665
- Followers520
- Likes3.9K
Emily Ward retweeted
Very excited about this! BEAT-PCD.org is very easy to remember! Bookmark for go-to page for PCD news, webinars and ressources. Including patients involvement and support groups
BEAT-PCD has reached the final step in its digital transformation!
Explore our new, simplified website at beat-pcd.org for faster access to resources, research, and community updates.
Emily Ward retweeted
Diagnostic criteria for invasive pulmonary aspergillosis in #COPD patients
doi.org/10.1093/ajrccm/aamag… @atscommunity
Emily Ward retweeted
🆕 New Phase 3 results in early-stage #lungcancer.
In resectable stage II–IIIB NSCLC, perioperative atezolizumab + chemotherapy achieved median event-free survival of 62.8 vs 34.9 months with chemotherapy alone.
bioengineer.org/perioperativ…
#WCLC26 #LCSM
Emily Ward retweeted
Higher baseline eosinophils and FeNO associated with real life Super-responders to Dupilumab
sciencedirect.com/science/ar…
Emily Ward retweeted
If you do one thing this #WorldSuicidePreventionDay please check out these 2 new @rcpsych resources
✔️Coproduced
✔️Compassionate
✔️Evidence-informed
✔️Practical
✔️Making a Safety Plan
✔️Talking to someone you're worried about
Delighted to contribute hope people find them helpful
Emily Ward retweeted
A busy few days at ERS presenting some of my PhD data and talking all things EMBARC 🫁
Emily Ward retweeted
We are delighted to announce Dr Jayanth Kumar Narayana @JayanthKumarNa7 as a touchRESPIRATORY Future Leader 2026!
Working at the intersection of data science and respiratory medicine, Dr Jayanth Kumar Narayana applies mathematical modelling, statistical learning, and microbiome analysis to advance understanding of bronchiectasis and improve approaches to precision care.
In this interview, he reflects on what inspired his career path, a defining breakthrough in his research, and the innovations in bronchiectasis and the respiratory microbiome that excite him most.
Read more:
touchrespiratory.com/insight…
#touchRESPIRATORY #FutureLeaders #RespiratoryMedicine #CriticalCare #Bronchiectasis
Want to reduce your hospitalisations, deaths and use of critical care? Vaccinate your patients!
Lovely data from Dr Fu and collegues
Fantastic overview of use of tobramycin nebulisers and eradication of pseudomonas in patients with BE from Jin-fu Xu
Perhaps we can ditch the ciprofloxacin and the many risky side effects? Exciting data to see
#ERSCongress
Macrolides work in bronchiectasis. Lovely to see an analysis of this from @MattiaNigro23. Next up some longer term studies!
#ERSCongress
Bronchoscopy washout with N-acetylcysteine found a significant difference in time to first exacerbation in BE vs BAL with saline or standard care.
Great to hear how the rest of the world are trialling BE treatments data from Hongying Ma #ERSCongress
“With a greater understanding of biology there is a greater understanding of therapeutics”
AZU-1 is associated with worse disease severity but what happens to the cilia?
If you add AZU-1 to cilia it slows them down
Fantastic insights from @Shoemelia @dundeeuni #ERSCongress
EMBARC paper below shows that those who develop bronchiectasis in childhood have worse disease in adulthood.
What factors affect disease resolution? Study here showing those who do/don’t. #pseudomoas associated with worse outcomes
#ERSCongress
Did you know bacteria can use microplastics to better invade the respiratory tract? Incredible to see the data carried out in Barcelona demonstrating this.
#ERSCongress
#airpollution #zerowaste
Really interesting to hear how INBARC (Indian bronchiectasis registry) is using a platform style approach to recruit patients to the registry & further trials.
This looks one to watch
#ERSCongress
Shout out to all the EMBARC teams





























